Canaccord Genuity Maintains Buy on Blend Labs, Lowers Price Target to $3

Benzinga Newsdesk www.benzinga.com Negative 68.7%

Neg 68.7% Neu 0% Pos 0%

Canaccord Genuity analyst Joseph Vafi maintains Blend Labs (NYSE:BLND) with a Buy and lowers the price target from $4.5 to $3.